1 w ·Translate

🔬 FDA Immediately Approves Drug That’s Doubling Lifespan for Late Pancreatic Cancer Patients

The drug daraxonrasib is approved for use in patients after chemotherapy has failed.

Via Good News Network

FDA Immediately Approves Drug That’s Doubling Lifespan for Late Pancreatic Cancer Patients
Favicon 
www.goodnewsnetwork.org

FDA Immediately Approves Drug That’s Doubling Lifespan for Late Pancreatic Cancer Patients

Pancreatic cancer has long been a death sentence, and a rapid one at that, but a new two-a-day pill has seen patients live twice as long even after chemotherapy fails. “Surviving” cancer refers to living more than 5 years post-diagnosis. Under that criteria, just 3% of patients survive pancreatic ca